Loading clinical trials...
Loading clinical trials...
Efficacy and Safety of flexibly dosed pregabalin compared to placebo among subjects with central post stroke pain (CPSP)
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
NCT03901352 · Central Neuropathic Pain
NCT06422117 · Central Neuropathic Pain
NCT01324232 · Central Neuropathic Pain, Multiple Sclerosis
NCT02059096 · Multiple Sclerosis With Central Neuropathic Pain
NCT04665492 · Central Neuropathic Pain, Spinal Cord Injuries
Pfizer Investigational Site
Darlinghurst, New South Wales
Pfizer Investigational Site
East Gosford, New South Wales
Pfizer Investigational Site
St Leonards, New South Wales
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions